INSP - Comprehensive Filing Intelligence

FY•10-K•Filed Feb 13, 2026

6.0/10

Filing Health:GOOD

Solid fundamentals with minor concerns to monitor

Executive Summary

Revenue growth continues, driven by market penetration and awareness, but at a decelerating rate due to external factors and market maturation.. Gross margins are strong and slightly improving, aided by product mix, but subject to inventory charges and potential cost pressures.. The company is involved in patent litigation with Nyxoah, with no disclosed financial exposure.. Revenue increased 13.6% to $912.0 million.

Top Concerns

!Gross margins are strong and slightly improving, aided by product mix, but subject to inventory charges and potential cost pressures.
!Impairment charge on strategic investments ($4.0M) requires scrutiny for valuation and recoverability.
!Substantial increase in advertising and D&A expenses warrant monitoring for impact on profitability.
!The company is involved in patent litigation with Nyxoah, with no disclosed financial exposure.
!General legal proceedings are ongoing, with uncertain outcomes and no specific financial disclosure.

Top Positives

+Revenue growth continues, driven by market penetration and awareness, but at a decelerating rate due to external factors and market maturation.
+Gross margins are strong and slightly improving, aided by product mix, but subject to inventory charges and potential cost pressures.
+Operating expenses, particularly SG&A, increased significantly, outpacing revenue growth and impacting operating leverage.

Analysis Dimensions

Our 5-pass AI analysis examines this filing across multiple dimensions. Each dimension score is derived from direct analysis of SEC filing text.

Narrative Intelligence

6.0/10

Management tone is balanced with focus on increased sales volume.

Full analysis includes: tone changes vs prior quarter, margin driver breakdown, forward guidance analysis, strategic priorities.

Accounting Quality

7.0/10

Earnings quality shows moderate accounting practices.

Full analysis includes: reserve and allowance changes, non-recurring item analysis, stock-based compensation impact, disclosure concerns.

Hidden Liabilities

Off-balance sheet risk is low.

Full analysis includes: cloud and purchase commitments, VIE/SPE exposure, covenant compliance status, refinancing risk assessment.

Risk Landscape

3.0/10

Overall risk profile shows regulatory compliance and reimbursement as primary concern.

Full analysis includes: 8 risk categories with severity, new vs escalated risks, management response assessment, risk trend analysis.

Segment Performance

7.0/10

Segment health analysis.

Full analysis includes: segment-by-segment revenue breakdown, geographic concentration risk, customer concentration analysis, segment margin trends.